Commission Implementing Decision

of 26 April 2011

allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134

(notified under document C(2011) 2668)

(Text with EEA relevance)

(2011/252/EU) (revoked)